Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 42NETWORK 6NIH 3INDUSTRY 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3Gynecologic 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 14Prostatic Neoplasms 3Gliosarcoma 3Glioblastoma 3Central Nervous System Neoplasms 3Vaginal Neoplasms 2Pancreatic Neoplasms 2Esophageal Neoplasms 2Endometrial Neoplasms 2Brain Neoplasms 2Vulvar Neoplasms 1Uveitis 1Uveal Melanoma 1Sarcoma 1Precancerous Conditions 1Papillomavirus Infections 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms 1Malignant mesenchymal tumor 1Locally Advanced Cervical Adenocarcinoma 1Liposarcoma 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Fibrosarcoma 1Esophageal Squamous Cell Carcinoma 1Desmoplastic Small Round Cell Tumor 1Choroid Neoplasms 1Carcinosarcoma 1Carcinoma, Ovarian Epithelial 1

Interventions

Docetaxel 26Prednisone 16Magnetic Resonance Spectroscopy 16Specimen Handling 15PROSTVAC 14Biopsy 12Goserelin 11bicalutamide 10Leuprolide 9sargramostim 8Estramustine 8Radiotherapy 7Lycopene 7High-Intensity Focused Ultrasound Ablation 7Flutamide 7Bevacizumab 7enzalutamide 6Thalidomide 6Mitoxantrone 62-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 6ixabepilone 5olaparib 4cediranib 4Tomography, X-Ray Computed 4Radiation 4Nivolumab 4Magnetic Resonance Imaging 4Androgen Antagonists 4Amplified Fragment Length Polymorphism Analysis 4temsirolimus 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × Prostatic Neoplasms × Brachytherapy × Clear all
NCT00924027 2025-09-05

A Study of Patients Receiving High-Dose Rate Brachytherapy

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
43 enrolled 13 charts
GastrointestinalGenitourinaryGynecologic

Biliary Tract Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

NCT00039624 2018-08-02

Magnetic Resonance-Guided High-Dose Brachytherapy (Short-Range Radiation Therapy) for Prostate Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
12 enrolled
Genitourinary

Prostatic Neoplasms

NCT00005939 2013-11-06

Brachytherapy in Treating Patients With Recurrent Prostate Cancer

National Cancer Institute (NCI)

Phase 1/2 Unknown
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡